CareTrust REIT (CTRE) and Its Competitors Financial Analysis

CareTrust REIT (NYSE:CTRE – Get Free Report) is one of 40 public companies in the “Healthcare REITs” industry, but how does it compare to its competitors? We will compare CareTrust REIT to similar businesses based on the strength of its earnings, valuation, profitability, risk, analyst recommendations, institutional ownership and dividends.

Dividends

CareTrust REIT pays an annual dividend of $1.56 per share and has a dividend yield of 4.1%. CareTrust REIT pays out 98.1% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. As a group, “Healthcare REITs” companies pay a dividend yield of 4.1% and pay out 121.7% of their earnings in the form of a dividend. CareTrust REIT has increased its dividend for 3 consecutive years. CareTrust REIT is clearly a better dividend stock than its competitors, given its higher yield and lower payout ratio.

Insider and Institutional Ownership

87.8% of CareTrust REIT shares are owned by institutional investors. Comparatively, 60.4% of shares of all “Healthcare REITs” companies are owned by institutional investors. 0.7% of CareTrust REIT shares are owned by insiders. Comparatively, 3.1% of shares of all “Healthcare REITs” companies are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Valuation & Earnings

This table compares CareTrust REIT and its competitors gross revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
CareTrust REIT $482.83 million $320.54 million 23.96
CareTrust REIT Competitors $1.23 billion $1.61 million -11.39

CareTrust REIT’s competitors have higher revenue, but lower earnings than CareTrust REIT. CareTrust REIT is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.

Profitability

This table compares CareTrust REIT and its competitors’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
CareTrust REIT 59.18% 8.08% 6.06%
CareTrust REIT Competitors 26.19% 6.15% 3.48%

Risk & Volatility

CareTrust REIT has a beta of 0.77, meaning that its share price is 23% less volatile than the S&P 500. Comparatively, CareTrust REIT’s competitors have a beta of 0.85, meaning that their average share price is 15% less volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of current recommendations and price targets for CareTrust REIT and its competitors, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CareTrust REIT 0 4 10 1 2.80
CareTrust REIT Competitors 423 2011 1999 86 2.39

CareTrust REIT currently has a consensus target price of $43.71, indicating a potential upside of 14.74%. As a group, “Healthcare REITs” companies have a potential upside of 11.29%. Given CareTrust REIT’s stronger consensus rating and higher possible upside, analysts plainly believe CareTrust REIT is more favorable than its competitors.

Summary

CareTrust REIT beats its competitors on 12 of the 15 factors compared.

CareTrust REIT Company Profile

(Get Free Report)

CareTrust REIT, Inc. is a real estate investment trust that owns and invests in healthcare-related properties, with a focus on skilled nursing facilities and senior housing. Its portfolio also includes assisted living and other properties that serve older adults and people requiring healthcare services. The company primarily works with healthcare operators through long-term property leases and other real estate investments. CareTrust’s properties are located across the United States, and the company has expanded its investments into the United Kingdom.

Receive News & Ratings for CareTrust REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CareTrust REIT and related companies with MarketBeat.com's FREE daily email newsletter.